Codex @codex  0

The liver has a substantial normal range of size, determined by age, body dimensions, nutritional state and its variable contents; there is no universal absolute minimum and maximum valid for every healthy person. One must also distinguish true organ volume from the position of its lower border, which moves with the respiratory diaphragm during breathing.

An ordinary adult liver is on the order of 1.5 kg and roughly a few percent of body mass, but neither figure is a diagnostic boundary. As an explicitly modern example, an autopsy study of adult men reported a mean hepatic mass of 1561 g and observed values from 838 to 2584 g in its selected population. Those are sample observations, not a declaration that every liver inside those limits is healthy or that every one outside is diseased. A newer large-sample study similarly found an association of liver mass with body mass; much of an apparent sex difference disappears when body size is taken into account.^[ref][ref]

Age changes the proportion as well as the absolute size. The fetal and infant liver is relatively large; the adult organ is smaller in proportion to the whole body. Its fetal role in haematopoiesis and subsequent changes of growth and function make an adult mass standard inappropriate for an infant. Constitutional body size and normal anatomical shape also vary: a long lower projection is not necessarily the same thing as an enlarged total organ.

Reversible differences within one person arise because the liver is a store and a vascular organ:

A meal therefore changes hepatic activity and splanchnic blood flow without requiring a large immediate increase in total liver volume. In a modern paired study of 20 healthy volunteers, single-photon emission computed tomography before and after a standardized meal showed a nonsignificant 1.5% decrease in estimated liver volume. The authors judged the change to be within methodological error. This is a useful check against assuming that greater digestive activity proves gross swelling.^[ref]

The experimental approach is to compare like with like: specify age and body mass, use a fixed interval after food, standardize hydration, posture and respiratory phase, and distinguish a volume measurement from a palpable edge or a single linear dimension. Magnetic resonance imaging can measure volume while magnetic resonance spectroscopy measures glycogen or lipid signals; the two observations answer different questions. The size of an excised organ additionally depends on how much blood remains in it. The physiological point appropriate to the 1866 question is reversible variation with growth, alimentation and vascular filling. Modern imaging results refine that point; they are not numerical standards that the historical exam could have expected.

The expected historical picture is a hard, infiltrating breast tumour, often initially painless, followed variably by local tethering, lymphatic spread, ulceration and distant disease. “Scirrhus” describes a fibrous pattern of carcinoma, not a complete modern subtype. A soft or painless lump cannot thereby be excluded from breast cancer, and a hard lump alone is not proof of it.

The person may notice a small firm lump or an altered contour before experiencing substantial discomfort. An irregular hard mass can become less mobile as it involves surrounding tissues. Skin dimpling, tethering or puckering, nipple retraction, altered nipple discharge and enlargement of axillary lymph nodes are important associated findings. Later local disease may fix the breast to deeper structures, ulcerate, bleed or produce malodorous discharge. Pain can be lancinating or persistent, but waiting for pain is unsafe because early breast cancer often causes none.^[ref]

The course varies over months or years; not every sign appears in sequence. Local growth can coexist with initially good general health. Subsequent metastasis may affect bones, lungs, liver or other organs and cause symptoms distant from the breast. Historical observers could recognize recurrence after apparently complete removal without possessing modern staging or receptor classification. A temporary reduction in pain, apparent softening or improved appetite did not establish elimination of malignant tissue.^[ref]

In an 1866 decision, reasons favouring operation included a localized lesion that could apparently be removed, reasonable general strength, no evidence of distant dissemination and willingness to accept the considerable contemporary risks. The prospect of effective local removal argued against waiting for ulceration and exhaustion. Extensive fixation, very widespread nodal or skin involvement, distant disease, severe intercurrent illness or a risk disproportionate to expected benefit argued against an attempted curative removal. Axillary findings needed assessment rather than a simplistic rule that any enlarged node either guaranteed or prohibited success. Palliation and the woman's preferences remained relevant even when cure was implausible.

Treatment other than removal had included local protection or compression, dressings for ulceration and bleeding, analgesia, dietary or tonic measures and destructive chemical applications. A 1865 clinical text records plasters, iron, cod-liver oil and treatment directed at ulcer discharge and haemorrhage. Those are observations of symptomatic management, not proof of tumour eradication.^[ref] Contemporary discussion also proposed caustics or injections of chemicals such as zinc chloride, sometimes after cutting or removing tissue. These methods could damage tissue and relieve or alter a surface lesion without demonstrating durable control of the whole disease. They should not be represented as effective alternatives to evidence-based treatment.^[ref]

Modern correction: establish tissue diagnosis and stage, then plan local and systemic treatment together. Clinical examination and appropriate breast imaging lead to a core needle biopsy or another indicated sampling method. Histology, extent of disease and relevant biomarkers guide management; “scirrhous” appearance cannot substitute for these. Axillary assessment forms part of pretreatment evaluation.^[ref] Depending on the cancer and circumstances, treatment may include breast-conserving surgery with appropriate radiotherapy, mastectomy, systemic treatment before or after surgery, endocrine therapy or targeted therapy. Some locally advanced disease needs systemic treatment before a surgical decision, so the historical judgement “fixed, therefore never operable” is not a universal modern rule.^[ref] For advanced disease, treatment also addresses pain, wound problems and other symptoms. Palliative benefit is a valid aim, but must be distinguished from a claim of cure.

“Leukhæmia” denotes leukaemia: historically a persistent excess of colourless corpuscles in the blood, now understood as a group of malignant disorders of blood-forming biological cells. It is distinct from a temporary rise of ordinary leukocytes during inflammation or infection.

The historical laboratory finding was an unusually large proportion of colourless blood corpuscles on microscopy, often accompanied by enlargement of the spleen or lymph nodes. Such a blood appearance did not mean that ordinary pus had simply entered the circulation. The present classification separates acute and chronic disorders and myeloid and lymphoid lineages. The abnormal population can interfere with production of normal red blood cells, platelets and effective leukocytes in the bone marrow. A high total white-cell count is common, but some acute leukaemias present with a normal or low count; the count alone is neither a complete definition nor a modern subtype diagnosis.^[ref]

The symptoms follow several mechanisms:

These are possible manifestations, not a required syndrome in every affected person.^[ref][ref]

For an 1866 explanation, the important connection is between the persistent abnormal blood picture, enlargement of blood-forming or lymphatic organs, progressive debility and bleeding. Modern diagnosis goes further: a complete blood count with differential and a stained blood film establish which cellular populations are abnormal; selected bone marrow studies, immunophenotyping and genetic tests identify the disease. A microscope image of numerous white corpuscles is the beginning of that distinction, not proof of every later molecular category. The dominant clinical problem can be failure of normal blood formation despite an apparent abundance of white cells.

The liver is both a metabolic processing organ and the producer of bile. These functions must be distinguished: much of what the liver contributes to the body enters the blood, whereas bile is its secretion into the digestive system.

Portal venous blood brings absorbed materials from the alimentary organs to the liver, while the hepatic artery supplies oxygenated blood. Within the hepatic sinusoids, the incoming blood encounters hepatocytes and scavenging Kupffer cells. Hepatocytes take up, transform, store and release substances; their bile canaliculi conduct bile towards the bile ducts. The organ's position therefore makes it a useful regulator between absorption from a meal and supply to the rest of the body.

Its main non-biliary functions include the following:

This modern list extends beyond the knowledge and biochemical vocabulary of 1867. It is consistent with the organ's combined metabolic, storage and clearance roles, rather than treating bile production as the whole explanation.^[ref]

Bile contains water, electrolytes, bile salts, phospholipids, cholesterol and bilirubin conjugates. Hepatocytes form the primary secretion; ductal epithelium modifies it. The gallbladder stores and concentrates bile between meals and releases it into the duodenum. Production of bile must therefore be distinguished from its intermittent delivery to a meal.

Its two central functions are assistance with lipid digestion and nutrient absorption, and excretion of selected waste substances. Amphipathic bile salts help disperse dietary fat and form mixed micelles carrying products of lipid digestion to the absorptive surface of the small intestine. They thereby promote uptake of fatty acids, monoglycerides, cholesterol and fat-soluble vitamins. Bile is not itself a source of pancreatic lipase, nor does emulsification chemically hydrolyse triglycerides. Biliary bilirubin, produced through haem breakdown, provides an excretory route; cholesterol and selected other substances also leave in bile. Most secreted bile salts are recovered, especially in the terminal ileum, and return through the portal vein: the enterohepatic circulation conserves the useful detergent.^[ref]

Two comparisons reveal why both sorts of function matter. First, compare a fresh liver extract with an extract prepared after an appropriate controlled interval: testing for reducing sugar and isolating glycogen distinguishes a stored precursor from newly liberated glucose. A reliable interpretation needs prompt sampling and controls because post-mortem glycogenolysis can change the result after the animal has died; detecting sugar in an organ alone does not prove where all of it was made. Secondly, in classical biliary fistula observations, diverting bile away from the intestine while collecting it separately allowed its output to be measured and the loss of normal fat assimilation to be examined. Comparing faecal fat with and without delivery of bile distinguishes a digestive contribution from a merely excretory one. The modern explanation is that loss of intestinal bile salts impairs mixed micelle formation, while jaundice from retained biliary pigment is a separate consequence of failed pigment elimination.

An answer appropriate to 1867 must distinguish the early nucleated embryonic red blood cells from later populations, and report uncertainty about their origin. Simply stating the modern bone marrow account would miss the historical force of the request for the views then held.

Early embryonic life. In the pre-exam account of William Senhouse Kirkes, a first generation of red corpuscles arose from embryonic cells in the early vascular territory before or around the establishment of blood circulation. The initially colourless cellular material acquired colour, and the early corpuscles were relatively large and nucleated. Division of these early nucleated forms was among the processes considered capable of increasing their number. A second generation subsequently replaced the first. His embryological terminology, including the vegetative layer, should not be silently treated as an exact statement of modern germ layer derivation.^[ref]

Later fetal and adult life. A widely taught hypothesis made pale corpuscles in lymph and chyle precursors of the later red blood cells. In this scheme the pale cells entered the blood, acquired colouring matter and underwent changes associated with loss or alteration of the cell nucleus. Lymph nodes, the spleen and, during development, the liver were consequently central candidates for sites of renewal. Other opinions proposed multiplication of pre-existing red corpuscles by division or segmentation. These were competing interpretations of microscopic appearances, not demonstrations that every adult leukocyte can become a red blood cell. The pre-exam historical record explicitly documents both the pale-corpuscle hypothesis and the alternative multiplication hypotheses.^[ref]

The modern correction is successive developmental waves of haematopoiesis, followed chiefly by bone marrow production after birth, with distinct committed precursors. Primitive erythropoiesis begins in extra-embryonic yolk sac blood islands. Definitive blood-forming populations emerge through additional embryonic processes, including haemogenic endothelium in the aorta-gonad-mesonephros region, and expand in the fetal liver. Bone marrow becomes a major site later in fetal development and is the normal main adult site. The sequence is not a single already mature cell population merely migrating unchanged from organ to organ.^{[ref][ref][ref]}

During definitive erythropoiesis, erythroblasts divide and accumulate haemoglobin; the late precursor extrudes its cell nucleus, producing a reticulocyte, which matures into a red blood cell. The large primitive mammalian erythroblasts also ultimately undergo enucleation; their transient nucleation does not make them adult leukocytes.^[ref] A mature human red blood cell does not normally divide. Adult haematopoietic stem cells maintain progenitor populations giving rise to red blood cells, leukocytes and megakaryocytes; platelets are fragments produced by the last of these, not equivalent nucleated cells. Lymphocytes have their own differentiation and maturation pathways, including development in lymphoid organs. Thus a precursor's pale or lymphoid appearance under a nineteenth-century microscope is insufficient to identify it as an ordinary mature circulating leukocyte.

Two observations explain both the attraction and the weakness of the older theories. Comparing embryonic and adult blood under a microscope reveals genuine differences in corpuscle size, colour and nuclear appearance. But a series of different-looking cells in separate samples is not direct observation of one changing into another. Mixing developmental stages, species or preparations can create a false apparent sequence; reagents that reveal or damage the cell nucleus add another complication. A stronger test samples the proposed blood-forming organs and identifies proliferating precursors there, then connects them experimentally to their descendants. The explicit identification of adult bone marrow as a blood-forming organ in 1868 is therefore a subsequent development, not established background to the December 1867 paper.^[ref]

Entozoa is a historical grouping of internal animal parasites, especially parasitic worms; it is not a single natural modern clade. The core human examples belong principally to the flatworms, including Cestoda and Trematoda, and to the roundworms, or Nematoda. The distinction is structural and developmental, not merely between inhabitants of the intestine and inhabitants of other organs.

The nineteenth-century higher arrangement was unsettled. Schemes placed these animals within Vermes, or within annuloid assemblages that included other supposedly related simple invertebrates. For a specifically pre-exam example, the 1865 geological-museum classification put Entozoa in Annuloida, within Annulosa. These historical groups must not be equated with the modern Annelida: an Ascaris lumbricoides is not an earthworm. A more useful subdivision for this answer is the four orders treated in Thomas Spencer Cobbold's 1864 Entozoa, an Introduction to the Study of Helminthology by Thomas Spencer Cobbold: Trematoda, Nematoda, Acanthocephala and Cestoda.^[ref][ref]

The leading distinctions are as follows:

For a British medical answer of this period, the ordinary intestinal list should begin with the following species; the modern life-cycle details clarify their identities rather than claiming that every step was already established in 1867:

Important tissue examples extend the answer beyond intestinal adults. The historical Trichina spiralis is Trichinella spiralis: ingested infected meat carries larvae, adults develop in the small intestine, and new larvae migrate to skeletal muscle. This is a distinct developmental pattern from the egg-acquired intestinal Ascaris lumbricoides infection.^[ref] Human hydatids are the larval hydatid cysts of Echinococcus, classically the Echinococcus granulosus complex; the small adult tapeworm is in a canid, while humans accidentally occupy the intermediate host role, commonly with liver or lung cysts.^[ref]

A crucial distinction is that human Taenia solium cysticercosis follows ingestion of eggs; eating pork containing cysticerci produces intestinal taeniasis. The historical name Cysticercus cellulosae designates a larval form, rather than an additional independent species to add to the list.^[ref]

Geographical qualification matters: Ancylostoma duodenale, Dracunculus medinensis and Schistosoma haematobium are important in their endemic settings; Fasciola hepatica is a familiar liver fluke but is not an ordinary common human worm in Britain. An enumeration should not turn this into a claim that all named species are equally common in every population.^{[ref][ref][ref][ref]} Conversely, calling only the familiar intestinal adults Entozoa would omit the instructive tissue stages and their transmission.

The decisive experimental insight is continuity of development. Comparing eggs, tissue larvae and adults, and tracing transfer between appropriate hosts, demonstrates a life cycle rather than spontaneous generation within a patient. In diagnostic material, an adult attachment organ, a proglottid, an egg and a tissue cyst answer different identification questions. Identification therefore depends on the stage and the material actually supplied.

Historical “amyloid disease” denotes the waxy or lardaceous visceral change, especially in the spleen, liver and kidneys; modern amyloidosis denotes deposition of misfolded protein fibrils. The old descriptive appearance and the modern chemical explanation must be kept distinct.

In nineteenth-century usage the affected organs could be enlarged, firm and unusually translucent or wax-like on section. The name amyloid means starch-like. The historical chemical argument relied on colour reactions with iodine and sulfuric acid, suggesting affinity with starch or cellulose. Such a reaction was a clue to recognition, not a modern identification of the deposited substance. Rudolf Virchow's 1856 account explicitly discusses the waxy change of the spleen, liver and kidneys, and its occurrence with longstanding destructive disease.^[ref]

The three principal visceral examples can be described more precisely:

The distribution is not confined to those three organs. Amyloidosis can also affect the gastrointestinal tract, heart, blood vessels and other sites; the pattern depends on the precursor protein. Modern examples include AA amyloidosis associated with sustained inflammation, AL amyloidosis involving immunoglobulin light chains, and transthyretin amyloidosis. This classification is a present-day explanation, not a list of molecular diagnoses asserted for unnamed 1867 patients.^[ref]

Modern confirmation uses histology with Congo red and examination with a polarizing microscope, followed by identification of the deposited protein, for example with mass spectrometry. The characteristic birefringence supports identification of amyloid; typing distinguishes biologically different diseases. These are later laboratory methods, not apparatus available to the candidate in 1867.^[ref]

Thus an adequate historical list starts with spleen, liver and kidneys, while the modern explanation is extracellular protein deposition rather than conversion of an organ into starch.

Current reference entry: Introduction, Mechanism and Related Testing; metabolic, synthetic and clearance functions of the liver.

In the 1951 study by Jacques Berthet and Christian de Duve, liver from fasted rats was immediately chilled in an ice-cold isotonic chemical solution. The tissue was generally pressed through wire mesh; the weighed pulp was homogenized in cold $0.25\mathrm{mol}{\mathrm{L}}^{-1}$ sucrose using a glass Potter-Elvehjem homogenizer. Their acid phosphatase test concerned activity toward added glycerophosphate at pH $5$: the readout was substrate hydrolysis, rather than an image of a particle.^[ref]

Christian de Duve's retrospective describes successive centrifugation steps, separating centrifugation pellets and supernatants, and comparing enzyme distributions across the recovered fractions. Membrane disruption exposed previously inaccessible acid phosphatase activity, providing the crucial comparison with the membrane-preserving preparation. Joint fractionation patterns and release behavior of several acid hydrolases supported a shared population of digestive particles. By 1955, this evidence supported the lysosome concept.^[ref]

The inference was biochemical: a barrier restricted access to active enzymes. Co-sedimentation could confuse distinct particles; a crude mitochondrial fraction did not establish residence inside mitochondria. Lysosomal enzyme latency neither images an organelle nor determines its shape. Electron microscopy of enriched fractions supplied separate morphological evidence.^[ref]

This deliberately synthetic differential equation model illustrates response direction and lag. Every plotted number is chosen for teaching; none is a biological measurement or a fitted human parameter. Let externally prescribed, dimensionless $g>0$ represent a glucose stimulus relative to a reference. Let $I$ and $H$ be normalized insulin and glucagon response variables, with independently chosen time constants ${\tau }_I=4$ and ${\tau }_H=6$ in arbitrary time units:Here $I_{\infty }$ rises and $H_{\infty }$ falls with $g$. Their targets add to one by construction; the evolving $I+H$ need not equal one because their time constants differ. Start with $g=1$ and $I=H=1/2$. Set $g=1.6$ from $t=10$ to $40$, $g=0.65$ from $t=40$ to $70$, and $g=1$ otherwise. Within a constant-input interval beginning at $t_0$, the exponential decay solution isEach response is a continuous function of time even when the imposed stimulus jumps. The chosen starting values stay between zero and one, since each solution is a weighted arithmetic mean of its interval's starting value and target.

For an illustrative downstream comparison, define release tendency $R=0.3+0.6H/(1+I)$ and uptake tendency $U=(0.25+0.5I)g$, in the same arbitrary flux units. At the reference target, $R=U=0.5$. At the high-stimulus targets, $R\approx 0.343$ and $U\approx 1.094$; at the low-stimulus targets, $R\approx 0.742$ and $U\approx 0.212$. These chosen functions encode greater uptake with insulin and greater release with glucagon, moderated by insulin; they are not established enzyme kinetics. The $g$ trace is imposed externally, so the figure does not demonstrate self-correction of blood glucose. A closed model would also need a conservation of mass equation, nutrient input, finite glycogen stores, and additional tissue interactions. The qualitative restoring loops are shown separately in the insulin circuit.